Designing live bacterial therapeutics for cancer

Area of Science:

• Microbiology and Oncology
• Synthetic Biology and Genetic Engineering

Background:

• Human-associated bacteria form symbiotic relationships and can uniquely colonize tumor microenvironments.
• Tumor-colonizing bacteria, thriving in hypoxic and acidic conditions, present a potential avenue for cancer treatment.

Purpose of the Study:

• To provide a comprehensive review on the utilization of bacteria for cancer therapy.
• To discuss critical factors for selecting bacterial strains and engineering them for therapeutic drug production.

Main Methods:

• Review of current literature on bacterial cancer therapy.
• Analysis of strategies for strain selection, genetic engineering, and spatiotemporal drug delivery.
• Exploration of engineered bacteria designed for tumor targeting and treatment.

Main Results:

• Synthetic biology advancements allow safe and efficient programming of therapeutic drug production in bacteria.
• Engineered bacteria can be designed for selective tumor colonization and controlled drug release.

Conclusions:

• Bacterial cancer therapy offers a versatile approach with significant potential.
• Key considerations include strain selection, safety, anti-tumor efficacy, and precise drug delivery control.
• Further research into challenges and future prospects is crucial for harnessing bacterial therapies.